| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |